7-deoxynarciclasine and pancratistatin

7-deoxynarciclasine has been researched along with pancratistatin* in 3 studies

Reviews

1 review(s) available for 7-deoxynarciclasine and pancratistatin

ArticleYear
Chemistry, biology, and medicinal potential of narciclasine and its congeners.
    Chemical reviews, 2008, Volume: 108, Issue:6

    Topics: Amaryllidaceae Alkaloids; Antineoplastic Agents; Antiviral Agents; Humans; Isoquinolines; Molecular Structure; Phenanthridines; Stereoisomerism

2008

Other Studies

2 other study(ies) available for 7-deoxynarciclasine and pancratistatin

ArticleYear
Isolation and structural modification of 7-deoxynarciclasine and 7-deoxy-trans-dihydronarciclasine.
    Journal of natural products, 2006, Volume: 69, Issue:1

    As an extension of structure-activity relationship studies of pancratistatin (1), various techniques were first evaluated for separating the mixtures of 7-deoxynarciclasine (2b) and 7-deoxy-trans-dihydronarciclasine (3a) isolated from Hymenocallis littoralis. An efficient solution for that otherwise difficult separation then allowed the lactam carbonyl group of protected (4c and 5c) alcohols 2b and 3a to be reduced employing lithium aluminum hydride. Cleavage (TBAF followed by H2SO4) of the silyl ester/acetonide protected 6a gave amine 8. X-ray crystal structure determinations were employed to confirm the structures of 3,4-acetonide-5-aza-6-deoxynarciclasine (6b), 5-aza-6-deoxynarciclasine (8a), and 5-aza-6-deoxy-trans-dihydronarciclasine (9a, 9b). Against the murine P388 lymphocytic leukemia and a panel of human cancer cell lines, the parent natural products, 7-deoxynarciclasine (2b) and 7-deoxy-trans-dihydronarciclasine (3a), were found to generally be more cancer cell growth inhibitory (GI50 0.1 to <0.01 microg/mL) than the compounds with structural modifications such as amine 8 by a factor of 10 or more. The trans ring juncture of isocarbostyril 3a proved to be an important modification of narciclasine (2a) for improving cancer cell growth inhibition in this series.

    Topics: Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Isoquinolines; Leukemia P388; Mice; Molecular Structure; Narcissus; Plants, Medicinal; Stereoisomerism; Structure-Activity Relationship

2006
In vitro activities of two antimitotic compounds, pancratistatin and 7-deoxynarciclasine, against Encephalitozoon intestinalis, a microsporidium causing infections in humans.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:12

    The antiparasitic effect of a collection of compounds with antimitotic activity has been tested on a mammalian cell line infected with Encephalitozoon intestinalis, a microsporidian causing intestinal and systemic infection in immunocompromised patients. The antiparasitic effect was evaluated by counting the number of parasitophorous vacuoles detected by immunofluorescence. Out of 526 compounds tested, 2 (pancratistatin and 7-deoxynarciclasine) inhibited the infection without affecting the host cell. The 50% inhibitory concentrations (IC(50)s) of pancratistatin and 7-deoxynarciclasine for E. intestinalis were 0.18 microM and 0.2 microM, respectively, approximately eightfold lower than the IC(50)s of these same compounds against the host cells. Electron microscopy confirmed the gradual decrease in the number of parasitophorous vacuoles and showed that of the two life cycle phases, sporogony was more sensitive to the inhibitors than merogony. Furthermore, the persistence of meronts in some cells apparently devoid of sporonts and spores indicated that the inhibitors block development rather than entry of the parasite into the host cell. The occurrence of binucleate sporoblasts and spores suggests that these inhibitors blocked a specific phase of cell division.

    Topics: Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Division; Encephalitozoon; Encephalitozoonosis; Humans; Isoquinolines; Microscopy, Electron; Spores

2001